THE EVOLVING ROLE OF DISEASE-LEVEL PATIENT EXPERIENCE IN HEALTH TECHNOLOGY ASSESSMENT (HTA) AND REGULATORY DECISION-MAKING

被引:0
|
作者
Hudzik, A. [1 ]
Sandman, K. [2 ]
Pham, S. [3 ]
机构
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] AESARA, Acton, MA USA
[3] AESARA, Chapel Hill, NC USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCR6
引用
收藏
页码:S541 / S542
页数:2
相关论文
共 50 条
  • [1] Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes
    Street, Jackie
    Stafinski, Tania
    Lopes, Edilene
    Menon, Devidas
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (02) : 87 - 95
  • [2] THE ROLE OF HEALTH RISK ASSESSMENT IN REGULATORY DECISION-MAKING
    SCROGGIN, DG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 194 : 26 - CHAL
  • [3] Interchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making?
    Ascef, Bruna de Oliveira
    Leonel da Silva, Renan Goncalves
    de Oliveira Junior, Haliton Alves
    De Soarez, Patricia Coelho
    CADERNOS DE SAUDE PUBLICA, 2019, 35 (09):
  • [4] SIMILARITIES AND DIFFERENCES IN HEALTH TECHNOLOGY ASSESSMENT (HTA) BODIES CONSIDERATIONS FOR DECISION-MAKING: USE OF PATIENT PREFERENCE STUDIES
    Morrison, S.
    Kumari, C.
    Castellano, G.
    Heinz, S.
    VALUE IN HEALTH, 2023, 26 (12) : S373 - S373
  • [5] EXPLORING THE ROLE OF PATIENT EXPERIENCE DATA AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT DECISION MAKING
    Alonzo, C.
    Genel, T.
    Kostikas, M.
    Krol, M.
    VALUE IN HEALTH, 2023, 26 (12) : S346 - S346
  • [6] Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making
    Tadrous, Mina
    Aves, Theresa
    Fahim, Christine
    Riad, Jessica
    Mittmann, Nicole
    Prieto-Alhambra, Daniel
    Rivera, Donna R.
    Chan, Kelvin
    Lix, Lisa M.
    Kent, Seamus
    Dawoud, Dalia
    Guertin, Jason Robert
    Mcdonald, James Ted
    Round, Jeff
    Klarenbach, Scott
    Stanojevic, Sanja
    Vera, Mary A. De
    Strumpf, Erin
    Platt, Robert W.
    Husein, Farah
    Lambert, Laurie
    Hayes, Kaleen N.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2024, 176
  • [7] COMMON THREADS: REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIESAVTM RECOMMENDATIONS ON REAL-WORLD EVIDENCE (RWE) USE IN DECISION-MAKING
    Jaksa, A.
    Gatto, N.
    Case, A.
    VALUE IN HEALTH, 2020, 23 : S315 - S316
  • [8] PATIENT VOICE AND PATIENT ENGAGEMENT IN VALUE ASSESSMENT FRAMEWORKS AND HTA DECISION-MAKING FOR GENE THERAPIES
    Dabbous, M.
    Raza, J.
    Connelly, B.
    Olid, Gonzalez A.
    Sullivan, N.
    VALUE IN HEALTH, 2024, 27 (06) : S312 - S312
  • [9] ANALYSIS OF FACTORS ASSOCIATED WITH REIMBURSEMENT DECISION MAKING IN HEALTH TECHNOLOGY ASSESSMENT (HTA)
    Bending, M. W.
    Kruger, J.
    Hutton, J.
    McGrath, C.
    VALUE IN HEALTH, 2009, 12 (03) : A11 - A11
  • [10] Patient perspectives on continuous glucose monitoring system (CGMS) for diabetes in Malaysia: a vital voice in health technology assessment (HTA) informing decision-making
    Mohamad, Nur Farhana
    Sani, Ana Fizalinda Abdullah
    Nizam, Nurfarah Aqilah Ahmad
    Sze-Shir, Foo
    Ghazali, Izzuna Mudla Mohamed
    Sarimin, Roza
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2025, 41 (01)